MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Calcium Supplementation for a Healthy Weight (CaSHeW)

Not Applicable

Completed

Conditions: Obesity
Overweight

Interventions: Dietary Supplement: Orange Juice fortified with Calcium and Vitamin D
Dietary Supplement: Orange juice without Ca or VitD
Behavioral: Nutritional Counseling

First Posted Date: 2011-06-01

Last Posted Date: 2011-06-01

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 130

Registration Number: NCT01363115

Locations: 🇺🇸
Massachusetts General Hospital Weight Center, Boston, Massachusetts, United States

Magnetic Resonance Spectroscopic and Diffusion Tensor Imaging of Adolescents with Autism Spectrum Disorders

Completed

Conditions: Autism Spectrum Disorders

First Posted Date: 2011-05-26

Last Posted Date: 2024-12-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 20

Registration Number: NCT01361503

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
McLean Hospital, Belmont, Massachusetts, United States

Effectiveness of a Relaxation-Response Based Cognitive Behavioral Therapy Group for Depressed Chinese Patients

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: Relaxation Response and Cognitive Behavioral Therapy

First Posted Date: 2011-05-25

Last Posted Date: 2013-05-10

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 40

Registration Number: NCT01359839

Locations: 🇺🇸
South Cove Community Health Center, Boston, Massachusetts, United States

Proton Radiation Therapy for Gliomas

Not Applicable

Active, not recruiting

Conditions: Low Grade Glioma
WHO Grade 3 Glioma With 1p/19q Codeletion
WHO Grade 3 Glioma With IDH1 Mutation

Interventions: Radiation: Proton radiation

First Posted Date: 2011-05-23

Last Posted Date: 2024-03-27

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 63

Registration Number: NCT01358058

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Cabozantinib (XL184) in Men With Castrate-Resistant Prostate Cancer

Phase 1

Completed

Conditions: Prostate Adenocarcinoma

Interventions: Drug: cabozantinib

First Posted Date: 2011-05-04

Last Posted Date: 2016-11-28

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 34

Registration Number: NCT01347788

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

High Dose Intensity Modulated Proton Radiation Treatment +/- Surgical Resection of Sarcomas of the Spine, Sacrum and Base of Skull

Not Applicable

Active, not recruiting

Conditions: Chordoma of Spine
Chordoma of Base of Skull
Chordoma of Sacrum
Chondrosarcoma of the Spine
Chondrosarcoma of the Sacrum

Interventions: Radiation: High Dose Intensity Modulated Proton Radiation

First Posted Date: 2011-05-02

Last Posted Date: 2020-09-03

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 64

Registration Number: NCT01346124

Locations: 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Laparoscopy-Assisted Transanal Endoscopy Rectosigmoid Resection for Rectal Cancer

Not Applicable

Completed

Conditions: Adenocarcinoma of the Rectum

Interventions: Procedure: Transanal endoscopic surgery

First Posted Date: 2011-04-25

Last Posted Date: 2017-09-06

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 5

Registration Number: NCT01340755

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Proton Radiation Therapy for Invasive Breast Cancer Following Mastectomy

Not Applicable

Conditions: Invasive Breast Cancer

Interventions: Radiation: Proton Radiation

First Posted Date: 2011-04-22

Last Posted Date: 2021-01-05

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 70

Registration Number: NCT01340495

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Study of Probiotic GanedenBC30 for Irritable Bowel Syndrome and Major Depressive Disorder

Phase 4

Terminated

Conditions: Major Depressive Disorder
Irritable Bowel Syndrome

Interventions: Drug: Ganeden BC30
Other: Placebo (sugar pill)
Other: Ganeden BC30, Placebo (sugar pill)

First Posted Date: 2011-04-19

Last Posted Date: 2013-08-09

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 5

Registration Number: NCT01337609

Locations: 🇺🇸
Burlington Medical Associates, Burlington, Massachusetts, United States
🇺🇸
Charles River Medical Associates, Westborough, Massachusetts, United States

A Study of Memantine Hydrochloride (Namenda®) for Cognitive and Behavioral Impairment in Adults With Autism Spectrum Disorders

Phase 4

Completed

Conditions: Autism Spectrum Disorders

Interventions: Drug: Memantine

First Posted Date: 2011-04-12

Last Posted Date: 2024-07-01

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 25

Registration Number: NCT01333865

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy